Adding metformin to the oral contraceptive treatment for hirsutism has no additional effect on Ferriman-Gallwey scores in hirsute women with PCOS: A randomized controlled study

• Published in: Gynecology, obstetrics & reproductive medicine : GORM Vol. 10; no. 2; pp. 101 - 105
• Main Authors: ELTER, Koray, İMİR, Gonca, DURMUŞOĞLU, Fatih, AY, Emine
• Format: Journal Article
• Language: English
• Published: MEBAS Medikal Basın 2004
• Subjects: Contraceptives, Oral; Cyproterone Acetate; Deri ve bağ dokusu hastalıkları; Dişi genital hastalıkları ve gebelik komplikasyonları; Doğum kontrol ajanları; Female genital diseases and pregnancy complications; Gebelik önleyiciler, oral; Hirsutism; Hirsutizm; Metformin; Polikistik yumurtalık sendromu; Polycystic Ovary Syndrome; Reproductive control agents; Siproteron asetat; Skin and connective tissue diseases
• ISSN: 1300-4751

OBJECTIVE: To analyze the additional benefits of adding metformin to the oral contraceptive pill (OCP) treatment in lean women with PCOS. STUDY DESIGN: After a baseline work-up including BMI, waist-to-hip ratio, Ferriman-Gallwey (FG) score, serum hormone, SHBG, fasting glucose and insulin levels, 28 nonobese women with PCOS were randomized either to the OCP or to the OCP-plus-metformin treatment. At the end of the 4-month follow-up period, subjects were re-evaluated. RESULTS: The two groups were similar at baseline. The effects of the two treatments on the FG score were similar. Subjects, who received OCP-plus-metformin had significantly higher reductions in serum androstenedione than those, who received OCP alone. Fasting glucose-to-insulin ratio improved significantly in the OCP-plus-metformin group, while OCP treatment alone did not cause any significant change. CONCLUSIONS: Adding metformin to the OCP treatment may result in additional benefits, but does not improve hirsutism over the OCP treatment alone.